Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Beaumont Bio Med Issues Voluntary Recall of all Homeopathic Aqueous/Alcohol-Based Medicines

By The U.S. Food and Drug Administration | September 7, 2018

Beaumont Bio Med, Inc. is voluntarily recalling its entire aqueous/alcohol-based product line for human use, within expiry, to the consumer level. All products manufactured by the contract manufacturer, King Bio, have been recalled due to possible microbial contamination.

The administration or use of drug products with microbial contamination could potentially result in increased infections that may require medical intervention, and could result in infections that could be life threatening to certain individuals. To date, Beaumont Bio Med has not received any reports of adverse events related to this recall.

The products being recalled are listed in this table: 

Product Names Size/Packaging/Dosage Form NDC Number Lot Number Expire Date
Skin Irritation & Itch Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7002 7 091515C
09/2018
Skin Irritation & Itch Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7002 7
050118S
05/2021
Sinus Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7013 7 100316A
10/2109
SoreThroat & Laryngitis Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7014 7 100316G
10/2019
SoreThroat & Laryngitis Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7014 7 050118R
05/2021
Diarrhea Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7022 7 090915
09/2018
Muscle & Joint Pain Relief 2 Fl Oz, Amber Glass, Oral Spray 58066 7041 7 012916F
01/2019
Allergy & Hay Fever Relief 2 Fl Oz, Amber Glass, Oral Spray 58066 7011 7 050216X
05/2019
Cold & Flu Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7012 7 042816C
04/2019
Cold & Flu Response 2 Fl Oz, Amber Glass, Oral Spray 58066 7012 7 112317K
11/2020
Arthritis Pain Relief 2 Fl Oz, Amber Glass, Oral Spray 58066 7042 7 112317K
01/2019

(Source: The U.S. Food and Drug Administration) 

Related Articles Read More >

Financial penalty
GSK, Pfizer and J&J among the most-fined drug companies, according to study
Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems
Flu vaccination worries rise in South Korea following deaths
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards